LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Founded by Harry Rickerby, James Field, and Rhys Algar in 2012, LabGenius is backed by investors that include Atomico, Lux Capital, Felicis Ventures, Charlie Songhurst, and Kindred Capital and is headquartered in London.